Literature DB >> 7895533

Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, complement activation, and endogenous PAF production.

X Sun1, M S Caplan, Y Liu, W Hsueh.   

Abstract

C3H/HeJ (endotoxin-resistant) mice have been used widely in biological research. However, the mechanism of endotoxin (LPS) resistance is only partially understood. In this study, we first investigated the differences in response to PAF, a mediator of endotoxin shock, between normal and C3H/HeJ mice. We found that in control mice, PAF (2.5 micrograms/kg) caused shock, hemoconcentration, complement activation, intestinal hypoperfusion, and necrosis with 75% mortality, whereas all C3H/HeJ mice survived, without complement activation or intestinal injury, and manifesting only mild hypotension and hemoconcentration. PAF also caused elevated serum TNF-alpha in some control mice but not in C3H/HeJ mice. We also observed that PAF induces endogenous PAF production and intestinal phospholipase A2 activation in normal mice, whereas PAF production and phospholipase A2 are suppressed in C3H/HeJ mice. The low endogenous PAF production may account, at least in part, for the resistance to LPS and PAF of C3H/HeJ mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895533     DOI: 10.1007/bf02064356

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids.

Authors:  F Snyder
Journal:  Proc Soc Exp Biol Med       Date:  1989-02

3.  Intravascular release of platelet activating factor in children with sepsis.

Authors:  F Bussolino; M G Porcellini; L Varese; A Bosia
Journal:  Thromb Res       Date:  1987-12-01       Impact factor: 3.944

4.  Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide.

Authors:  R N Apte; O Ascher; D H Pluznik
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

5.  Genetic control of lipopolysaccharide induced generation of serum colony stimulating factor and proliferation of splenic granulocyte/macrophage precursor cells.

Authors:  R N Apte; D H Pluznik
Journal:  J Cell Physiol       Date:  1976-10       Impact factor: 6.384

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

Authors:  F H Chilton; J M Ellis; S C Olson; R L Wykle
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

8.  Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.

Authors:  W Hsueh; F Gonzalez-Crussi; J L Arroyave
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

9.  Blood levels of platelet-activating factor in endotoxin-sensitive and endotoxin-resistant mice during endotoxemia.

Authors:  T W Chang; M H Wu; Y J Yang
Journal:  J Formos Med Assoc       Date:  1992-12       Impact factor: 3.282

10.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

View more
  8 in total

1.  Characterization of a necrotizing enterocolitis model in newborn mice.

Authors:  Runlan Tian; Shirley Xl Liu; Cara Williams; Thomas D Soltau; Reed Dimmitt; Xiaotian Zheng; Isabelle G De Plaen
Journal:  Int J Clin Exp Med       Date:  2010-09-21

2.  Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

Authors:  P E Watkins; B F Warren; S Stephens; P Ward; R Foulkes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

3.  Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor.

Authors:  Isabelle G De Plaen; Xin-Bing Han; Xueli Liu; Wei Hsueh; Sankar Ghosh; Michael J May
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

Review 4.  Pathogenesis of necrotizing enterocolitis: modeling the innate immune response.

Authors:  Scott M Tanner; Taylor F Berryhill; James L Ellenburg; Tamas Jilling; Dava S Cleveland; Robin G Lorenz; Colin A Martin
Journal:  Am J Pathol       Date:  2014-11-04       Impact factor: 4.307

5.  Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model.

Authors:  Jing Lu; Tamas Jilling; Dan Li; Michael S Caplan
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

Review 6.  Paneth cells and necrotizing enterocolitis.

Authors:  Mark A Underwood
Journal:  Gut Microbes       Date:  2012-08-16

Review 7.  The benefits, limitations and opportunities of preclinical models for neonatal drug development.

Authors:  Sarah Campion; Amy Inselman; Belinda Hayes; Costanza Casiraghi; David Joseph; Fabrizio Facchinetti; Fabrizio Salomone; Georg Schmitt; Julia Hui; Karen Davis-Bruno; Karen Van Malderen; LaRonda Morford; Luc De Schaepdrijver; Lutz Wiesner; Stephanie Kourula; Suna Seo; Susan Laffan; Vijay Urmaliya; Connie Chen
Journal:  Dis Model Mech       Date:  2022-04-25       Impact factor: 5.732

Review 8.  Precision-based modeling approaches for necrotizing enterocolitis.

Authors:  Mark L Kovler; Chhinder P Sodhi; David J Hackam
Journal:  Dis Model Mech       Date:  2020-06-24       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.